Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy.
暂无分享,去创建一个
[1] Joseph Cappello,et al. Genetically Engineered Protein Polymers , 1998 .
[2] Hamidreza Ghandehari,et al. Silk-elastinlike recombinant polymers for gene therapy of head and neck cancer: from molecular definition to controlled gene expression. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[3] M. Haider,et al. Genetically engineered polymers: status and prospects for controlled release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[4] J. Feijen,et al. Polymeric Drug Delivery Systems , 1980 .
[5] Meredith A Mintzer,et al. Nonviral vectors for gene delivery. , 2009, Chemical reviews.
[6] S. Hoag,et al. Influence of solute charge and hydrophobicity on partitioning and diffusion in a genetically engineered silk-elastin-like protein polymer hydrogel. , 2010, Macromolecular bioscience.
[7] Yong Wang,et al. Systemic dissemination of viral vectors during intratumoral injection. , 2003, Molecular cancer therapeutics.
[8] Hamidreza Ghandehari,et al. Silk‐elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors , 2010, The journal of gene medicine.
[9] B. Åkerman. Effects of supercoiling in electrophoretic trapping of circular DNA in polyacrylamide gels. , 1998, Biophysical journal.
[10] Joseph Kost,et al. Handbook of Biodegradable Polymers , 1998 .
[11] H. Ghandehari,et al. Delivery of bioactive agents from recombinant polymers , 2007 .
[12] J. Cappello,et al. In-situ self-assembling protein polymer gel systems for administration, delivery, and release of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[13] M. Haider,et al. Silk-elastinlike hydrogels: Thermal characterization and gene delivery , 2006 .
[14] S. Carter. The carcinogenic potential of cytotoxic chemotherapy and its implications for therapeutic decision-making , 2004, Cancer Chemotherapy and Pharmacology.
[15] Hamidreza Ghandehari,et al. Solute diffusion in genetically engineered silk-elastinlike protein polymer hydrogels. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[16] F. Rosner. Opinion: Is chemotherapy carcinogenic? , 1978, CA: a cancer journal for clinicians.
[17] D. Teplow,et al. Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.
[18] S. Radford,et al. Hierarchical Assembly of β2-Microglobulin Amyloid In Vitro Revealed by Atomic Force Microscopy , 2003 .
[19] Franco A. Ferrari,et al. Biosynthesis of Protein Polymers , 1997 .
[20] U. Scheler,et al. Scaling Behaviour of PAMAM Dendrimers Determined by Diffusion NMR , 2005 .
[21] Wonseok Hwang,et al. Surface Induced nanofiber growth by self-assembly of a silk-elastin-like protein polymer. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[22] Paul Symonds,et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis , 2001, The Lancet.
[23] Kinam Park,et al. Controlled drug delivery : challenges and strategies , 1997 .
[24] Hamidreza Ghandehari,et al. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[25] L. Chandler,et al. Matrix‐enabled gene transfer for cutaneous wound repair , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[26] M. Haider,et al. Recombinant polymers for cancer gene therapy: a minireview. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[27] Hamidreza Ghandehari,et al. Controlled Release of Plasmid DNA from a Genetically Engineered Silk-Elastinlike Hydrogel , 2002, Pharmaceutical Research.
[28] Hamidreza Ghandehari,et al. Influence of polymer structure and biodegradation on DNA release from silk-elastinlike protein polymer hydrogels. , 2009, International journal of pharmaceutics.
[29] S. G. Smith,et al. The amino acid sequence in a fraction of the fibroin of Bombyx mori. , 1957, The Biochemical journal.
[30] Huei-Chen Ko,et al. Study of hepatotoxicity of naltrexone in the treatment of alcoholism. , 2006, Alcohol.
[31] H. Ertl,et al. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.
[32] F. Yuan,et al. A novel method for viral gene delivery in solid tumors. , 2005, Cancer research.
[33] C. Bokemeyer,et al. Evaluation of long-term toxicity after chemotherapy for testicular cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] H. Ghandehari,et al. Characterization of Structurally Related Adenovirus-laden Silk-elastinlike Hydrogels , 2008 .
[35] Mansoor M. Amiji,et al. Polymeric Gene Delivery : Principles and Applications , 2004 .
[36] Hamidreza Ghandehari,et al. Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors. , 2009, Biomacromolecules.
[37] M. Fändrich,et al. The aggregation kinetics of Alzheimer's β‐amyloid peptide is controlled by stochastic nucleation , 2005, Protein science : a publication of the Protein Society.
[38] H. Ghandehari,et al. Genetically engineered silk-elastinlike protein polymers for controlled drug delivery. , 2002, Advanced drug delivery reviews.
[39] S. Andreadis,et al. Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[40] M. Marquet,et al. Genetic Engineering of Structural Protein Polymers , 1990, Biotechnology progress.
[41] C. Bokemeyer,et al. Endocrinological late effects after chemotherapy for testicular cancer. , 1996, British Journal of Cancer.
[42] Xiang Gao,et al. Nonviral gene delivery: What we know and what is next , 2007, The AAPS Journal.
[43] A. Cresce,et al. Silk–elastinlike protein polymer hydrogels: Influence of monomer sequence on physicochemical properties , 2009 .
[44] E. Wagner,et al. Bioresponsive polymers for nonviral gene delivery. , 2009, Current opinion in molecular therapeutics.
[45] L. Duan,et al. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] J. G. Leslie,et al. Elastin structure, biosynthesis, and relation to disease states. , 1981, The New England journal of medicine.
[47] Pete R. Jemian,et al. Irena: tool suite for modeling and analysis of small‐angle scattering , 2009 .
[48] W. Bauer,et al. Physical properties and gel electrophoresis behavior of R12-derived plasmid DNAs. , 1977, Nucleic acids research.
[49] M. Haider,et al. Molecular engineering of silk-elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization. , 2005, Molecular pharmaceutics.
[50] Hamidreza Ghandehari,et al. Swelling behavior of a genetically engineered silk-elastinlike protein polymer hydrogel. , 2002, Biomaterials.
[51] Hamidreza Ghandehari,et al. Characterization and real-time imaging of gene expression of adenovirus embedded silk-elastinlike protein polymer hydrogels. , 2008, Molecular pharmaceutics.
[52] A. Hatefi,et al. Adenoviral Gene Delivery to Solid Tumors by Recombinant Silk–Elastinlike Protein Polymers , 2007, Pharmaceutical Research.
[53] A. M. Bueche,et al. Scattering by an Inhomogeneous Solid , 1949 .
[54] Leelee Ong,et al. Localized and Sustained SDF-1 Gene Release Mediated by Fibronectin Films: A Potential Method for Recruiting Stem Cells , 2009, The International journal of artificial organs.
[55] R. Coimbra,et al. The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. , 2009, Biomaterials.
[56] Adam Bagg,et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.